Stay updated on KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Sign up to get notified when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.
Latest website image capture
Clouds background image

Latest updates to the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    - The study record now shows Revision: v3.6.6, replacing the prior v3.6.5. This appears to be a metadata version update rather than a substantive change to study data or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-29T19:58:42.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5, replacing Revision: v3.6.4. This appears to be a routine site version update affecting only the underlying code/version label, not the study details.
    Difference
    0.1%
    Check dated 2026-08-08T22:32:40.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    New PubMed-listed publication citation was added to the Publications section (Cancer Res Commun. 2026) for the study. A PubMed auto-fill note with revision 3.6.4 was also included, clarifying the source of automatically pulled text.
    Difference
    0.2%
    Check dated 2026-07-25T13:13:00.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision tag in the page footer updated to Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor metadata update to the page without changing study content or eligibility details.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:17.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.0 to v3.6.2, reflecting a newer build version.
    Difference
    0.1%
    Check dated 2026-06-27T01:05:27.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    New user guidance and join-related navigation items have been added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study). The label formatting for Intervention/Treatment was updated, and a site revision note (Revision: v3.6.0) is shown.
    Difference
    0.5%
    Check dated 2026-06-12T14:29:15.000Z thumbnail image

Stay in the know with updates to KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer

Enter your email address, and we'll notify you when there's something new on the KEYDOX Trial: Doxorubicin & Pembrolizumab in Breast Cancer page.